Common Contracts
2 similar Asset Purchase Agreement contracts by Day One Biopharmaceuticals, Inc., X4 Pharmaceuticals, Inc
ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 8, 2024 (the “Effective Date”) by and between [***] (“Buyer”) and X4 PHARMACEUTICALS, INC., a Delaware corporation (“Seller”). Buyer and...Asset Purchase Agreement • August 8th, 2024 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Delaware
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO DAY ONE BIOPHARMACEUTICALS IF PUBLICLY DISCLOSED. ASSET PURCHASE AGREEMENT BY AND...Asset Purchase Agreement • August 2nd, 2024 • Day One Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 29, 2024 (the “Effective Date”) by and between [*] (“Buyer”) and DAY ONE BIOPHARMACEUTICALS, INC., a Delaware corporation (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties.”
